Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, Two-Part, Multi-Center, First-in-Human Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

NCT04707248 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04707248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04707248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, Two-Part, Multi-Center, First-in-Human Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors
Lead sponsor
Daiichi Sankyo
Phase
Phase 1
Overall status
Active, not recruiting
Start date
December 22, 2020
Completion date
December 30, 2026
Enrollment
179 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian tumor, renal cell carcinoma